Yong Qing Cheng
Directeur Général chez Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profil
Yong Qing Cheng is the Chairman & General Manager of Beijing Tri Prime Gene Pharmaceutical Co., Ltd., which he founded in 1992.
He holds an MBA from China Europe International Business School, a graduate degree from Peking Union Medical College, and an undergraduate degree from West China School of Pharmacy.
Postes actifs de Yong Qing Cheng
| Sociétés | Poste | Début |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Directeur Général | 24/09/1992 |
Formation de Yong Qing Cheng
| China Europe International Business School | Masters Business Admin |
| Peking Union Medical College | Graduate Degree |
| West China School of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
